Search

In Stock

Buy Cabenuva (cabotegravir + rilpivirine) Online

DISEASE INDICATIONS: HIV/AIDS

MANUFACTURER: ViiV Healthcare

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Cabenuva is a combination medication used for the treatment of HIV-1 infection in adults who have already achieved viral suppression with a stable antiretroviral regimen. It is a novel therapy that offers a long-acting, injectable option for maintaining HIV suppression, offering potential benefits in terms of convenience and adherence.

From $3,894.54

Clear
Compare

Cabenuva is a combination medication used for the treatment of HIV-1 infection in adults who have already achieved viral suppression with a stable antiretroviral regimen. It is a novel therapy that offers a long-acting, injectable option for maintaining HIV suppression, offering potential benefits in terms of convenience and adherence. Here is a detailed description of Cabenuva (cabotegravir + rilpivirine):

1. Mechanism of Action: Cabenuva is a combination of two active ingredients: cabotegravir and rilpivirine. These medications work together to inhibit the replication of the human immunodeficiency virus (HIV-1).

  • Cabotegravir is an integrase strand transfer inhibitor (INSTI). It blocks the activity of the HIV-1 integrase enzyme, preventing the viral DNA from integrating into the host cell’s DNA. This step is crucial for HIV replication.
  • Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It inhibits the reverse transcriptase enzyme, which is responsible for converting viral RNA into DNA, a necessary step in the HIV life cycle.

2. Indications: Cabenuva is indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace their current antiretroviral regimen if their virus has been suppressed (viral load less than 50 copies per mL) on a stable antiretroviral regimen for at least six months with no history of treatment failure.

3. Administration: Cabenuva is administered by intramuscular injection once a month. It is given as two separate injections: one containing cabotegravir and the other containing rilpivirine. The injections are typically administered in the buttocks by a healthcare professional.

4. Effectiveness: Clinical studies have shown that Cabenuva is effective in maintaining viral suppression in people living with HIV-1. It provides an alternative to daily oral regimens, potentially improving adherence and treatment outcomes.

5. Safety Profile: As with any medication, Cabenuva may have potential side effects. Common side effects can include injection site reactions, headache, and fatigue. Serious side effects are rare but can include severe allergic reactions. Patients should discuss potential side effects and any concerns with their healthcare providers.

6. Monitoring: Patients receiving Cabenuva will require regular monitoring of their HIV viral load, CD4 cell count, and overall health to ensure that their HIV infection remains well-controlled.

7. Contraindications: Cabenuva is generally not recommended for individuals with known hypersensitivity to the active ingredients or any of the components in the medication. It is also not recommended for those with HIV-1 strains that are resistant to cabotegravir or rilpivirine.

8. Convenience: One of the primary benefits of Cabenuva is its long-acting injectable format, which reduces the need for daily pill-taking. This can be especially convenient for individuals who prefer or struggle with oral medications.

Cabenuva represents a significant advancement in HIV treatment by offering a novel and effective option for maintaining viral suppression with less frequent dosing. It is crucial for individuals living with HIV-1 to consult with a healthcare provider experienced in HIV care to determine the most appropriate treatment regimen for their specific condition and needs.

Package

1 vial of cabotegravir 400 mg and one vial of rilpivirine 600 mg, 1 vial of cabotegravir 600 mg and one vial of rilpivirine 900 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Rukobia (fostemsavir) Online

(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Rukobia, known by its generic name Fostemsavir, is a prescription medication used in the treatment of HIV-1 infection in adults who have limited treatment options due to resistance, intolerance, or other factors. It is classified as an attachment inhibitor, a novel class of antiretroviral drugs that work differently from traditional HIV medications.

Buy Cabenuva (cabotegravir + rilpivirine) Online

From $3,894.54
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare MEDICINE APPROVED BY: Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Cabenuva is a combination medication used for the treatment of HIV-1 infection in adults who have already achieved viral suppression with a stable antiretroviral regimen. It is a novel therapy that offers a long-acting, injectable option for maintaining HIV suppression, offering potential benefits in terms of convenience and adherence.

Buy Vocabria (cabotegravir) Online

$647.13
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Vocabria, known by its generic name Cabotegravir, is a prescription medication used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Buy Pifeltro (doravirine) Online

From $560.34
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: Merck USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Pifeltro, known by its generic name Doravirine, is a prescription medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It belongs to the class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Buy RoActemra (tocilizumab) Online

$2,358.15
(0 Reviews)
RoActemra, known by its generic name Tocilizumab, is a medication used to treat various autoimmune and inflammatory conditions. It belongs to a class of drugs known as interleukin-6 (IL-6) receptor antagonists. Tocilizumab helps to regulate the immune system by targeting the activity of the cytokine IL-6, which plays a key role in inflammation.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Truvada (emtricitabine / tenofovir disoproxil) Online

$774.62
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: Gilead Sciences International Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Truvada is a combination medication that contains two active ingredients: emtricitabine and tenofovir disoproxil. It is primarily used for the treatment and prevention of human immunodeficiency virus (HIV) infection.

Back to Top
Product has been added to your cart